Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers

Introduction. ER, PR, and HER2 are routinely available in breast cancer specimens. The purpose of this study is to contrast breast cancer-specific survival for the eight ER/PR/HER2 subtypes with survival of an immunohistochemical surrogate for the molecular subtype based on the ER/PR/HER2 subtypes a...

Descripción completa

Detalles Bibliográficos
Autores principales: Parise, Carol A., Caggiano, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058253/
https://www.ncbi.nlm.nih.gov/pubmed/24955090
http://dx.doi.org/10.1155/2014/469251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058253/
https://www.ncbi.nlm.nih.gov/pubmed/24955090
http://dx.doi.org/10.1155/2014/469251

Ejemplares similares